Delta Asia International Corporation (TPEX:6762)
145.00
+0.50 (0.35%)
May 7, 2026, 1:18 PM CST
Delta Asia International Revenue
Delta Asia International had revenue of 135.79M TWD in the quarter ending March 31, 2026, a decrease of -17.02%. This brings the company's revenue in the last twelve months to 666.31M, up 3.49% year-over-year. In the year 2025, Delta Asia International had annual revenue of 694.15M with 19.58% growth.
Revenue (ttm)
666.31M
Revenue Growth
+3.49%
P/S Ratio
7.65
Revenue / Employee
3.64M
Employees
183
Market Cap
5.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 694.15M | 113.64M | 19.58% |
| Dec 31, 2024 | 580.51M | 72.49M | 14.27% |
| Dec 31, 2023 | 508.02M | 45.05M | 9.73% |
| Dec 31, 2022 | 462.97M | -68.34M | -12.86% |
| Dec 31, 2021 | 531.32M | -23.00M | -4.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| United Orthopedic | 5.66B |
| Hi-Clearance | 4.28B |
| TaiDoc Technology | 4.20B |
| Wellell | 2.40B |
| OK Biotech | 1.56B |
| Dynamic Medical Technologies | 1.39B |
| WeLeader Biomedical | 1.11B |
| A Plus Biotechnology | 835.89M |